Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to ...
In late February 2026, Boston Scientific entered into a new US$3.00 billion revolving credit agreement maturing in 2031, while its board expanded the company’s share repurchase authorization to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results